Characterization of the Melanoma-Specific Immune Response
N/A
The aim of this study is to study T-cells. Blood will be collected and the ...
Status
Unknown
Location
University of California, Davis Department of Dermatology
Start Date
2007-08
Trial ID
NCT00368615
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
PHASE2
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
PHASE3
The percentage of malignant prostate tumors detected very early is constant...